Randomised phase III trial of radical chemo/radiotherapy vs radiotherapy alone in the definitive management of localised muscle invasive TCC of the urinary bladder

Primary Sponsor

Urological Society of Australasia

Collaborating Groups

Trans Tasman Radiation Oncology Group (TROG)

Final Accrual

67

Trial Chairperson

Dr Kumar Gogna, QRI Mater Centre, QLD

Trial Contact

Kumar Gogna

Clinical Trial Registration

Related Post

23 October, 2025

TROG collaboration sees international skin cancer trial open in Australia

LATEST NEWS: 23 October 2025 TROG Cancer Research has

21 October, 2025

Grandad’s mission to walk 10,000 steps a day to support cancer research

LATEST NEWS: 21 October 2025 Walking at least 10,000